Immunoglobulins, normal human, for intravascular [Power / Sample Size]

posted by Yura – Belarus, 2016-01-13 07:51 (3313 d 23:16 ago) – Posting: # 15817
Views: 6,467

Hi
How to calculate the sample size for the non-comparative trials for biosimilar, or what are the approaches to solving this problem?
Aim - assessment of treatment effectiveness (improvement in symptoms).
Best regards,
Yura

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,667 registered users;
141 visitors (0 registered, 141 guests [including 5 identified bots]).
Forum time: 07:07 CET (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5